Mike Nohaile is senior vice president of Strategy, Commercialization & Innovation at Amgen. Nohaile joined Amgen as vice president of Strategy in December 2012. Prior to Amgen, he served as the head and general manager of the Molecular Diagnostics Business Unit at Novartis. He also served Novartis as the head of Corporate Strategy and head of Pharmaceutical Strategy. Nohaile began his career at McKinsey & Company, as partner in the New Jersey office, where he worked extensively in the healthcare area with a particular focus on diagnostics, devices and pharmaceuticals. He has a doctorate in molecular and cell biology from University of California, Berkeley, and he was a postdoctoral fellow at MIT in the Department of Biology.